artemisinin has been researched along with Clerambault Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bu, JY; Chen, SQ; Chen, XH; Hu, JS; Li, Q; Liao, HJ; Lin, PY; Lin, SP; Wei, JX; Ye, S; Zhu, LD | 1 |
1 other study(ies) available for artemisinin and Clerambault Syndrome
Article | Year |
---|---|
Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Artemisinins; CA1 Region, Hippocampal; Cell Death; Cell Line; Cell Movement; Cytokines; Inflammation; Lipopolysaccharides; Male; Mice, Inbred C57BL; Microglia; Morris Water Maze Test; Neurocognitive Disorders; Neurons; Neuroprotective Agents; Sepsis; Signal Transduction | 2021 |